vs
Side-by-side financial comparison of BREAD FINANCIAL HOLDINGS, INC. (BFH) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
BREAD FINANCIAL HOLDINGS, INC. is the larger business by last-quarter revenue ($975.0M vs $493.8M, roughly 2.0× Pediatrix Medical Group, Inc.). On growth, BREAD FINANCIAL HOLDINGS, INC. posted the faster year-over-year revenue change (5.4% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -0.8%).
Bread Financial Holdings, Inc. is an American publicly traded provider of private label credit cards, coalition loyalty programs, and direct marketing, derived from the capture and analysis of transaction-rich data.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
BFH vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $975.0M | $493.8M |
| Net Profit | — | $33.7M |
| Gross Margin | — | — |
| Operating Margin | 4.9% | 9.9% |
| Net Margin | — | 6.8% |
| Revenue YoY | 5.4% | -1.7% |
| Net Profit YoY | — | 10.5% |
| EPS (diluted) | $1.21 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $975.0M | $493.8M | ||
| Q3 25 | $971.0M | $492.9M | ||
| Q2 25 | $929.0M | $468.8M | ||
| Q1 25 | $970.0M | $458.4M | ||
| Q4 24 | $925.0M | $502.4M | ||
| Q3 24 | $983.0M | $511.2M | ||
| Q2 24 | $939.0M | $504.3M | ||
| Q1 24 | $991.0M | $495.1M |
| Q4 25 | — | $33.7M | ||
| Q3 25 | $188.0M | $71.7M | ||
| Q2 25 | $139.0M | $39.3M | ||
| Q1 25 | $138.0M | $20.7M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | $2.0M | $19.4M | ||
| Q2 24 | $133.0M | $-153.0M | ||
| Q1 24 | $134.0M | $4.0M |
| Q4 25 | 4.9% | 9.9% | ||
| Q3 25 | 20.2% | 13.8% | ||
| Q2 25 | 18.7% | 12.8% | ||
| Q1 25 | 20.3% | 7.0% | ||
| Q4 24 | -2.9% | 7.8% | ||
| Q3 24 | 4.1% | 6.6% | ||
| Q2 24 | 19.2% | -31.3% | ||
| Q1 24 | 19.0% | 3.2% |
| Q4 25 | — | 6.8% | ||
| Q3 25 | 19.4% | 14.5% | ||
| Q2 25 | 15.0% | 8.4% | ||
| Q1 25 | 14.2% | 4.5% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | 0.2% | 3.8% | ||
| Q2 24 | 14.2% | -30.3% | ||
| Q1 24 | 13.5% | 0.8% |
| Q4 25 | $1.21 | $0.40 | ||
| Q3 25 | $3.96 | $0.84 | ||
| Q2 25 | $2.94 | $0.46 | ||
| Q1 25 | $2.78 | $0.24 | ||
| Q4 24 | $0.08 | $0.37 | ||
| Q3 24 | $0.05 | $0.23 | ||
| Q2 24 | $2.66 | $-1.84 | ||
| Q1 24 | $2.70 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6B | $375.2M |
| Total DebtLower is stronger | $4.3B | $570.5M |
| Stockholders' EquityBook value | $3.3B | $865.9M |
| Total Assets | $22.7B | $2.2B |
| Debt / EquityLower = less leverage | 1.29× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.6B | $375.2M | ||
| Q3 25 | $3.8B | $340.1M | ||
| Q2 25 | $3.8B | $224.7M | ||
| Q1 25 | $4.2B | $99.0M | ||
| Q4 24 | $4.0B | $229.9M | ||
| Q3 24 | $3.5B | $103.8M | ||
| Q2 24 | $4.1B | $19.4M | ||
| Q1 24 | $3.8B | $8.0M |
| Q4 25 | $4.3B | $570.5M | ||
| Q3 25 | $3.8B | $577.2M | ||
| Q2 25 | $4.2B | $583.9M | ||
| Q1 25 | $5.1B | $590.5M | ||
| Q4 24 | $5.6B | $597.1M | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $3.3B | $865.9M | ||
| Q3 25 | $3.3B | $890.7M | ||
| Q2 25 | $3.2B | $833.8M | ||
| Q1 25 | $3.1B | $789.2M | ||
| Q4 24 | $3.1B | $764.9M | ||
| Q3 24 | $3.1B | $732.5M | ||
| Q2 24 | $3.2B | $706.5M | ||
| Q1 24 | $3.0B | $856.2M |
| Q4 25 | $22.7B | $2.2B | ||
| Q3 25 | $21.7B | $2.2B | ||
| Q2 25 | $21.8B | $2.1B | ||
| Q1 25 | $22.4B | $2.0B | ||
| Q4 24 | $22.9B | $2.2B | ||
| Q3 24 | $21.7B | $2.1B | ||
| Q2 24 | $22.1B | $2.0B | ||
| Q1 24 | $22.3B | $2.2B |
| Q4 25 | 1.29× | 0.66× | ||
| Q3 25 | 1.14× | 0.65× | ||
| Q2 25 | 1.34× | 0.70× | ||
| Q1 25 | 1.67× | 0.75× | ||
| Q4 24 | 1.82× | 0.78× | ||
| Q3 24 | 1.47× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $568.0M | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $568.0M | $114.1M | ||
| Q3 25 | $605.0M | $137.3M | ||
| Q2 25 | $526.0M | $137.2M | ||
| Q1 25 | $393.0M | $-117.5M | ||
| Q4 24 | $479.0M | $133.0M | ||
| Q3 24 | $456.0M | $91.8M | ||
| Q2 24 | $477.0M | $107.0M | ||
| Q1 24 | $447.0M | $-125.2M |
| Q4 25 | — | 3.39× | ||
| Q3 25 | 3.22× | 1.91× | ||
| Q2 25 | 3.78× | 3.49× | ||
| Q1 25 | 2.85× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | 228.00× | 4.72× | ||
| Q2 24 | 3.59× | — | ||
| Q1 24 | 3.34× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BFH
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
